(Q44212235)

30 November 2017

title

BMI-independent inverse relationship of plasma leptin levels with outcome in patients with acute pulmonary embolism (English)

1 reference

30 November 2017

C Dellas

1 reference

30 November 2017

M Lankeit

1 reference

30 November 2017

C Reiner

1 reference

30 November 2017

K Schäfer

1 reference

30 November 2017

G Hasenfuß

1 reference

30 November 2017

S Konstantinides

1 reference

30 November 2017

language of work or name

English

0 references

publication date

20 March 2012

1 reference

International Journal of Obesity

30 November 2017

published in

1 reference

30 November 2017

1 reference

30 November 2017

1 reference

30 November 2017

page(s)

204-210

1 reference

Positional cloning of the mouse obese gene and its human homologue

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Leptin signaling and obesity: cardiovascular consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Inhibition of endogenous leptin protects mice from arterial and venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Leptin promotes vascular remodeling and neointimal growth in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Leptin enhances the potency of circulating angiogenic cells via src kinase and integrin (alpha)vbeta5: implications for angiogenesis in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Plasma leptin and prognosis in patients with established coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

A randomized trial of rosuvastatin in the prevention of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Molecular and anatomical determinants of central leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

High leptin levels are associated with stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Leptin, but not adiponectin, predicts stroke in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: The Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Low serum leptin predicts mortality in patients with chronic kidney disease stage 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Obesity paradox in patients with hypertension and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Obesity and the risk of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Body mass index and mortality in heart failure: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

CNS leptin action modulates immune response and survival in sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin,

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

Leptin signalling and leptin-mediated activation of human platelets: importance of JAK2 and the phospholipases Cgamma2 and A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

7 January 2021

Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

7 January 2021

Effect of leptin on arterial thrombosis following vascular injury in mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

7 January 2021

Leptin induces oxidative stress in human endothelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

7 January 2021

Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

7 January 2021

The metabolic syndrome and the risk of venous thrombosis: a case–control study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

7 January 2021

Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

7 January 2021

Squalamine, a novel cationic steroid, specifically inhibits the brush-border Na+/H+ exchanger isoform NHE3.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

7 January 2021

Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

7 January 2021

A leptin serum concentration less than 10 ng/ml is a predictive marker of outcome in patients with moderate to severe secondary peritonitis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

7 January 2021

Effect atorvastatin on serum tumor necrosis facor alpha and interleukin-1β following acute pulmonary embolism

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.36

7 January 2021

Identifiers

DOI

10.1038/IJO.2012.36

1 reference

Dimensions Publication ID

30 November 2017

1006165141

0 references

1 reference